Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 42
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Iorio A, Königs C, Reding MT, Rotellini D, Skinner MW, Mancuso ME, Berntorp E | 2023 | Haemophilia | View Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Health care providers | Clinical research |
Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, Goldman M, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Researchers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Reaffirmed Guideline No. 343: Routine Non-Invasive Prenatal Prediction of Fetal RHD Genotype | Health care providers | Benchmarking and standard setting |
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia | Karnes JH, Rollin J, Giles JB, Martinez KL, Steiner HE, Shaffer CM, Momozawa Y, Inai C, Bombin A, Shi M, Mosley JD, Stanaway I, Selleng K, Thiele T, Mushiroda T, Pouplard C, Heddle NM, Kubo M, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM | 2022 | Blood | View ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia | Researchers | Basic research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
The importance of iron for whole blood donors: a Canadian perspective | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Benchmarking and standard setting |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Benchmarking and standard setting |
FAQ: Canadian Blood Services platelet bacterial screening | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View FAQ: Canadian Blood Services platelet bacterial screening | Health care providers | Benchmarking and standard setting |
Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
Applying principles of patient blood management during COVID-19 pandemic: a literature review | Khandelwal A, Vandermeulen H, Tordon B, Pavenski K | 2022 | Annals of Blood | View Applying principles of patient blood management during COVID-19 pandemic: a literature review | Health care providers | Clinical research |
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? | Kirkham AM, Bailey AJM, Shorr R, Lalu MM, Fergusson DA, Allan DS | 2023 | Cytotherapy | View Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? | Researchers | Clinical research |
Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Kirpalani HM, Prokopchuk-Gauk O, Heddle NM | 2022 | JAMA Pediatr | View Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Health care providers | New or improved product or process |
Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository | Kumar R, Bakeer N, Dawson J, Al-Mughairy A, Stanek J, Dunn A, Male C, Chan A, Williams S | 2023 | J Thromb Haemost | View Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository | Researchers | Basic research |
Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia | Kwan C, Chan AK, Koh PL, Kadir NIA, Decker K, Lim CY, Lam JCM | 2022 | J Haem Pract | View Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia | Health care providers | Clinical research |
HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Lambert G, Cox J, Fourmigue A, Dvorakova M, Apelian H, Moodie EEM, Grace D, Skakoon-Sparling S, Moore DM, Lachowsky N, Jollimore J, Lal A, Parlette A, Hart TA | 2022 | Transfusion | View HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Researchers | MSM research |
Data for assessing red blood cell deformability from microscopy images using deep learning | Lamoureux ES, Islamzada E, Wiens MVJ, Matthews K, Duffy SP, Ma H | 2023 | Data Brief | View Data for assessing red blood cell deformability from microscopy images using deep learning | Researchers | New or improved product or process |
How do I provide rare red cells to patients? | Laureano M, Clarke G, Yan MTS | 2023 | Transfusion | View How do I provide rare red cells to patients? | Health care providers | Benchmarking and standard setting |
Chapter 10. Transfusion reactions | Laureano M, Khandelwal A, Yan M | 2022 | Clinical Guide to Transfusion | View Chapter 10. Transfusion reactions | Health care providers | Benchmarking and standard setting |
Chapitre 10. Les réactions transfusionnelles | Laureano M, Khandelwal A, Yan M | 2022 | Guide de la pratique transfusionnelle | View Chapitre 10. Les réactions transfusionnelles | Health care providers | Benchmarking and standard setting |
Investigation of Acute Transfusion Reactions | Leary H, Webert KE, Heddle NM | 2022 | Practical Transfusion Medicine | View Investigation of Acute Transfusion Reactions | Health care providers | Benchmarking and standard setting |
Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Leis M, Clarfield L, Lin Y, Gupta A, Da Luz L | 2023 | CJEM | View Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Health care providers | Benchmarking and standard setting |
Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study | Leong DP, Zhang A, Breznik JA, Clare R, Huynh A, Mushtaha M, Rangarajan S, Stacey H, Kim PY, Loeb M, Denburg JA, Mertz D, Chagla Z, Nazy I, Miller MS, Bowdish DME, Duong M | 2023 | PLoS One | View Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study | Researchers | Clinical research |
Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Blood operators | Benchmarking and standard setting |
c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Li F, Xiong Y, Yang M, Chen P, Zhang J, Wang Q, Xu M, Wang Y, He Z, Zhao X, Huang J, Gu X, Zhang L, Sun R, Sun X, Li J, Ou J, Xu T, Huang X, Cao Y, Xu XR, Karakas D, Li J, Ni H, Zhang Q | 2022 | Cell Death Dis | View c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance | Researchers | Basic research |
Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude | Li M, Tang X, Liao Z, Shen C, Cheng R, Fang M, Wang G, Li Y, Tang S, Xie L, Zhang Z, Kamau PM, Mwangi J, Lu Q, Li Y, Wang Y, MacKeigan DT, Cerenzia EG, Ni H, Lai R | 2022 | Blood | View Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude | Researchers | Basic research |
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Li N, Mahamad S, Parpia S, Iorio A, Foroutan F, Heddle NM, Hsia CC, Sholzberg M, Rimmer E, Shivakumar S, Sun HL, Refaei M, Hamm C, Arnold DM | 2022 | J Thromb Haemost | View Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia | Researchers | New or improved product or process |
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Li N, Zeller MP, Shih AW, Heddle NM, St. John M, Bégin P, Callum J, Arnold DM, Akbari-Moghaddam M, Down DG, Jamula E, Devine DV, Tinmouth A | 2022 | Transfusion | View A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Researchers | Clinical research |
Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Li W, Acker JP | 2022 | Clin Chim Acta | View Development and validation of a sensitive flow cytometric method for determining CECs in RBC products | Researchers | New or improved product or process |
Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Li W, William N, Acker JP | 2023 | Transfusion | View Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Researchers | Basic research |
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A, Landry D, La Rocca U, Lemyre B, Maier RF, Muniz-Diaz E, Nahirniak S, New HV, Pavenski K, Dos Santos MCP, Ramsey G, Shehata N, International Collaboration for Transfusion Medicine Guidelines | 2022 | Brit J Haem | View International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn | Health care providers | Benchmarking and standard setting |
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Lin Y, Khandelwal A, Kapitany C, Chargé S | 2023 | Transfus Apher Sci | View Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Health care providers | Education research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Liu B, Hadzi-Tosev M, Liu Y, Lucier KJ, Garg A, Li S, Heddle NM, Rochwerg B, Ning S | 2022 | Crit Care Explor | View Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Health care providers | Clinical research |
Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Liwski R, Clarke G, Cheng C, Abidi SSR, Abidi SR, Quinn JG | 2023 | Vox Sang | View Validation of a flow-cytometry-based red blood cell antigen phenotyping method | Health care providers | New or improved product or process |
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial | Ljung R, Chan AKC, Glosli H, Afonja O, Becker B, Tseneklidou-Stoeter D, Mancuso ME, Saulyte-Trakymiene S, Kenet G | 2023 | Thromb Haemost | View BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial | Researchers | Clinical research |
Small Molecule Drugs That Inhibit Phagocytosis | Loriamini M, Lewis-Bakker MM, Frias Boligan K, Wang S, Holton MB, Kotra LP, Branch DR | 2023 | Molecules | View Small Molecule Drugs That Inhibit Phagocytosis | Researchers | Basic research |
Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Lu W, Ziman A, Yan MTS, Waters A, Virk MS, Tran A, Tang H, Shih AW, Scally E, Raval JS, Pandey S, Pagano MB, Shan H, Moore C, Morrison D, Cormack O, Fitzgerald J, Duncan J, Corean J, Clarke G, Yazer M | 2023 | Transfusion | View Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Health care providers | Clinical research |
Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Ma W, Rousseau Z, Slavkovic S, Shen C, Yousef GM, Ni H | 2022 | Pharmaceuticals | View Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Researchers | Basic research |
FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Mack J | 2022 | Blood.ca website | View FAQ: Whole blood, leukocytes reduced (LrWB) at Canadian Blood Services | Health care providers | New or improved product or process |
FAQ : Le sang total déleucocyté à la Société canadienne du sang | Mack J | 2022 | Blood.ca website | View FAQ : Le sang total déleucocyté à la Société canadienne du sang | Health care providers | New or improved product or process |
FAQ : plasma traité au solvant-détergent (Octaplasma) | Mack J, Gordon I, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ : plasma traité au solvant-détergent (Octaplasma) | Health care providers | New or improved product or process |
FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Mack J, Gordon R, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Health care providers | New or improved product or process |
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia: reply | Mahamad S, Li N, Arnold DM | 2023 | J Thromb Haemost | View Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia: reply | Researchers | Clinical research |
Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management | Mahamad S, Modi D, Al-Samkari H, Cuker A, Despotovic JM, Italiano JE, Lambert MP, Lee EJ, Rondina MT, Sholzberg M, Kruse C, Larché M, Nazy I, Miller MS, Arnold DM | 2023 | Res Pract Thromb Haemost | View Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management | Health care providers | Clinical research |
Emicizumab state-of-the-art update | Mahlangu J, Iorio A, Kenet G | 2022 | Haemophilia | View Emicizumab state-of-the-art update | Health care providers | Clinical research |
Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia | Matusiak K, Patriquin CJ, Deniz S, Dzaja N, Smith JW, Wang G, Nazy I, Kelton JG, Arnold DM | 2022 | Transfusion | View Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia | Researchers | Clinical research |
The transfusion-associated dyspnea prospective observation and laboratory assessment study: a protocol for investigating and disambiguating cardiopulmonary and high-grade febrile transfusion reactions in adults | McVey M, Saeed S, Siddiqui R, Armali C, Kron A, Branch D, Brinc D, Zhang L, Shehata N, Pavenski K, Gupta A, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C | 2023 | Int J Clin Trials | View The transfusion-associated dyspnea prospective observation and laboratory assessment study: a protocol for investigating and disambiguating cardiopulmonary and high-grade febrile transfusion reactions in adults | Health care providers | Clinical research |